Obesity is a serious global health problem and a risk factor for numerous diseases. Adipose tissue plays a central role in the development of obesity; it comprises fat cells (known as adipocytes, which specialise in fat storage) and macrophages (the immune system’s ‘scavenger cells’, typically associated with the destruction of microbes).
A team of scientists from MedUni Vienna, in collaboration with researchers from Poland, Germany, Australia and Austria, has now identified the signalling pathways responsible for the development of a beneficial type of adipose tissue macrophage (ATMs) in obesity, which prevents lipotoxicity. Lipotoxicity is the process by which fat molecules are deposited in non-adipose tissues.
With the right signal (the PI3K signalling pathway), it is possible to induce phagocytes in the body to develop into specialised fat-eating cells, reports Gernot Schabbauer of MedUni Vienna. This prevents fat from entering the bloodstream and being deposited in the wrong tissues (non-adipose tissues), the researchers explain.
They discovered that sustained activation of the PI3K signalling pathway causes phagocytes in adipose tissue to produce increased levels of the ‘phagocytic receptor MARCO’ on their surfaces. This turns them into professional fat-eaters, enabling them to take up fat and break it down before it enters the bloodstream.
Subsequent studies will now aim to determine whether PI3K signalling can have a lasting effect on the macrophage population not only in animal models but also in humans.
References: MedUni Vienna; CeMM; University of Graz; University of Warsaw; University of Sydney, University of New South Wales
The PI3K pathway preserves metabolic health through MARCO-dependent lipid uptake by adipose tissue macrophages; Nature Metabolism 16 November 2020; https://www.nature.com/articles/s42255-020-00311-5